SCHEMBL2219490

SCHEMBL2219490

CCC(=O)Nc1cc(NS(=O)(=O)c2cc(OC)c(OC)c(OC)c2)ccc1OC

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.59
NPSR1 Q6W5P4 1/20 0.59
LMNA P02545 4/20 0.50
HTT P42858 3/20 0.50
EGFR P00533 1/20 0.49
ERBB2 P04626 1/20 0.49
ERBB4 Q15303 1/20 0.49
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
MAPK1 P28482 2/20 0.49
ALOX15 P16050 1/20 0.49
ALDH1A1 P00352 6/20 0.48
HDAC1 Q13547 1/20 0.46
NPC1 O15118 1/20 0.46
HPGD P15428 1/20 0.45
POLB P06746 1/20 0.45
MAPT P10636 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12436008 0.90 SMN1; SMN2 (0.56) SMN1; SMN2NPSR1LMNAHTTEGFR
SCHEMBL2218687 0.88 SMN1; SMN2 (0.59) SMN1; SMN2NPSR1LMNAHTTEGFR
SCHEMBL6340650 0.82 LMNA (0.48) SMN1; SMN2NPSR1LMNAHTTKMT2A
SCHEMBL12435989 0.80 SMN1; SMN2 (0.58) SMN1; SMN2NPSR1LMNAHTTEGFR
SCHEMBL9645055 0.79 HTT (0.60) SMN1; SMN2NPSR1HTTKMT2AMEN1
SCHEMBL12436015 0.78 LMNA (0.62) SMN1; SMN2NPSR1LMNAHTTKMT2A
SCHEMBL6350570 0.77 LMNA (0.60) SMN1; SMN2NPSR1LMNAHTTKMT2A
SCHEMBL2220169 0.77 KMT2A (0.51) SMN1; SMN2NPSR1LMNAHTTKMT2A
SCHEMBL12436016 0.76 LMNA (0.51) SMN1; SMN2NPSR1LMNAHTTEGFR
SCHEMBL6343513 0.75 LMNA (0.60) SMN1; SMN2NPSR1LMNAHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2351731-B1 A GROUP OF AMINO SUBSTITUTED BENZOYL DERIVATIVES AND THEIR PREPARATION AND THEIR USE INST MED BIOTECHNOLOGY CAMS (CN) 2016-02-10 EP disclosed
US-8710098-B2 Group of amino substituted benzoyl derivatives and their preparation and their use Institute of Medicinal Biotechnology Chinese Academy of Medical Science (CN) 2014-04-29 US disclosed
EP-2351731-A1 A GROUP OF AMINO SUBSTITUTED BENZOYL DERIVATIVES AND THEIR PREPARATION AND THEIR USE Institute Of Medicinal Biotechnology, Chinese Academy of Medical Sciences (CN) 2011-08-03 EP disclosed
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use Institute of Medicinal Biotechnology Academy of Medical Science (CN) 2011-07-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110178108-A1 Group of amino substituted benzoyl derivatives and their preparation and their use CUL3, APOBEC3G, BRPF3 SMN1; SMN2 4598/4885NPSR1 4225/4885LMNA 2812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.